Short-Term Effects of Beraprost Sodium on the Markers for Cardiovascular Risk Prediction in Type 2 Diabetic Patients with Microalbuminuria.

Yun Mi ChoiHyuk Sang KwonKyung Mook ChoiWon Young LeeEun Gyoung Hong

Published in: Endocrinology and metabolism (Seoul, Korea) (2020)

Short-term treatment of BPS for patients with diabetic nephropathy did not show significant improvement in various cardiovascular risk factors. However, BPS significantly decreased microalbuminuria in study subjects with higher cardiovascular risk such as high BP or large waist circumference.

Keyphrases

cardiovascular risk factors
diabetic nephropathy
body mass index
cardiovascular disease
metabolic syndrome
body weight
type diabetes